ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 166 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2018. The put-call ratio across all filers is 9.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $17,310,000 | -44.2% | 226,734 | -43.9% | 0.05% | -48.4% |
Q2 2018 | $31,042,000 | +51.0% | 403,813 | +0.2% | 0.10% | +43.9% |
Q1 2018 | $20,555,000 | +25.4% | 403,130 | +14.1% | 0.07% | +26.9% |
Q4 2017 | $16,387,000 | -10.0% | 353,302 | +3.4% | 0.05% | -13.3% |
Q3 2017 | $18,199,000 | -9.1% | 341,702 | +6.0% | 0.06% | -1.6% |
Q2 2017 | $20,030,000 | -7.0% | 322,497 | +1.5% | 0.06% | -16.4% |
Q1 2017 | $21,541,000 | +2.7% | 317,810 | +6.6% | 0.07% | -2.7% |
Q4 2016 | $20,970,000 | +5.1% | 298,243 | +6.0% | 0.08% | +8.7% |
Q3 2016 | $19,961,000 | +56.0% | 281,373 | +7.6% | 0.07% | +53.3% |
Q2 2016 | $12,794,000 | +1.0% | 261,583 | +30.8% | 0.04% | +2.3% |
Q1 2016 | $12,665,000 | -1.1% | 200,057 | +75.3% | 0.04% | +2.3% |
Q4 2015 | $12,803,000 | +21.4% | 114,122 | +4.2% | 0.04% | +13.2% |
Q3 2015 | $10,550,000 | -3.6% | 109,538 | +2.4% | 0.04% | +5.6% |
Q2 2015 | $10,948,000 | +44.7% | 106,934 | -12.2% | 0.04% | +50.0% |
Q1 2015 | $7,564,000 | +104.2% | 121,840 | +44.3% | 0.02% | +100.0% |
Q4 2014 | $3,705,000 | +231.7% | 84,460 | +328.0% | 0.01% | +200.0% |
Q3 2014 | $1,117,000 | +24.7% | 19,732 | -1.1% | 0.00% | +33.3% |
Q2 2014 | $896,000 | -8.3% | 19,959 | -0.1% | 0.00% | 0.0% |
Q1 2014 | $977,000 | – | 19,975 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |